We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Meritage Homes
MTH
$4.87B
| $921K | ﹤0.01% |
24,200
-11,600
| -32% | -$343K |
|
927
Oshkosh
OSK
$9.67B
| $919K | ﹤0.01% |
12,842
+5,656
| +79% | +$386K |
|
928
International Bancshares
IBOC
$4.77B
| $918K | ﹤0.01% |
28,700
+1,900
| +7% | +$54.6K |
|
929
Progress Software
PRGS
$1.55B
| $918K | ﹤0.01% |
23,700
+800
| +3% | +$30.5K |
|
930
Tenet Healthcare
THC
$20.1B
| $918K | ﹤0.01% |
50,700
-2,900
| -5% | -$57.1K |
|
931
SPX Corp
SPXC
$11B
| $917K | ﹤0.01% |
22,300
+900
| +4% | +$33.9K |
|
932
Tenable Holdings
TENB
$3.56B
| $915K | ﹤0.01% |
30,700
+1,400
| +5% | +$38K |
|
|
GRA
933
DELISTED
W.R. Grace & Co.
GRA
| $915K | ﹤0.01% |
18,017
| – | – |
|
934
Compañía de Minas Buenaventura
BVN
$7.85B
| $914K | ﹤0.01% |
100,000
| – | – |
|
935
Dana Inc
DAN
$2.91B
| $913K | ﹤0.01% |
74,900
-26,700
| -26% | -$290K |
|
|
WMGI
936
DELISTED
Wright Medical Group Inc
WMGI
| $912K | ﹤0.01% |
30,700
+11,600
| +61% | +$339K |
|
937
Hancock Whitney
HWC
$6.13B
| $909K | ﹤0.01% |
42,900
+2,100
| +5% | +$43.3K |
|
938
Liberty Media Series C
FWONK
$24.3B
| $908K | ﹤0.01% |
29,631
-2,898
| -9% | -$86.1K |
|
939
Cavco Industries
CVCO
$4.39B
| $906K | ﹤0.01% |
4,700
-500
| -10% | -$81.9K |
|
940
Xencor
XNCR
$1.44B
| $906K | ﹤0.01% |
28,000
+3,400
| +14% | +$104K |
|
941
AtriCure
ATRC
$1.77B
| $903K | ﹤0.01% |
20,100
-2,900
| -13% | -$126K |
|
942
Grocery Outlet
GO
$891M
| $902K | ﹤0.01% |
+22,125
| New | +$792K |
|
|
ESGR
943
DELISTED
Enstar Group
ESGR
| $901K | ﹤0.01% |
5,900
+500
| +9% | +$73.7K |
|
|
DISH
944
DELISTED
DISH Network Corp.
DISH
| $901K | ﹤0.01% |
26,131
-17,436
| -40% | -$485K |
|
945
Artisan Partners
APAM
$2.79B
| $900K | ﹤0.01% |
27,700
-2,600
| -9% | -$72.1K |
|
|
MGLN
946
DELISTED
Magellan Health Services, Inc.
MGLN
| $897K | ﹤0.01% |
12,300
-2,400
| -16% | -$154K |
|
947
Rambus
RMBS
$10.4B
| $896K | ﹤0.01% |
59,000
-2,600
| -4% | -$36.6K |
|
948
Insight Enterprises
NSIT
$3.55B
| $895K | ﹤0.01% |
18,200
+900
| +5% | +$44.3K |
|
|
DRNA
949
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $894K | ﹤0.01% |
35,200
-4,900
| -12% | -$106K |
|
|
ZEN
950
DELISTED
ZENDESK INC
ZEN
| $893K | ﹤0.01% |
+10,098
| New | +$777K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.